glp-1 drugs muscle loss Weight with medicines does not result in a disproportionate loss of mass or function in obese mice and humans New GLP-1 Weight-Loss Drug Mimics

65-year-old patient Enalapril + Furosemide Diclofenac added for pain Within days: Urine output dropped Creatinine spiked Diagnosis: This is the ACE inhibitor + Diuretic + NSAID Individually

Senile osteoporosis (type II): In the population over 65 years old, there is aging of osteoblasts and stem cells, decreased proliferation and differentiation ability, and insufficient bone formation

The effect of GLP1 receptor agonists on dementia risk might be highly heterogeneous in routine clinical practice, implying the need to identify individuals who are more likely to benefit from their neuroprotective effects

That's a government-run database listing thousands of ongoing studies

Archived from the original on 14 July 2014